Pfizer (PFE) Preferred Shares (2009 - 2020)
Pfizer (PFE) posted quarterly Preferred Shares of $17.0 million for Q1 2020, down 10.53% year-over-year from $19.0 million in Q1 2019, and little changed quarter-over-quarter from $17.0 million in Q4 2019.
Pfizer (PFE) Preferred Shares (2009 - 2020) Analysis & Trends
Pfizer (PFE) has reported Preferred Shares for 12 consecutive years, with $17.0 million the latest figure, recorded in Q1 2020.
- In Q1 2020, Preferred Shares fell 10.53% year-over-year to $17.0 million; the TTM figure through Mar 2020 stood at $17.0 million (down 10.53% YoY), while the FY2019 annual figure was $17.0 million, down 10.53% from the prior year.
- Preferred Shares steadied at $17.0 million in Q1 2020 per PFE's latest filing, from $17.0 million in the prior quarter.
- Across five years, Preferred Shares topped out at $26.0 million in Q2 2016 and bottomed at $17.0 million in Q4 2019.
- Historically, Preferred Shares has averaged $21.1 million across 5 years, with a median of $21.0 million in 2017.
- Annual changes were most pronounced in 2016 — Preferred Shares fell 7.14% — and 2018, when it fell 13.04%.
- Pfizer's Preferred Shares stood at $24.0 million in 2016, then retreated by 12.5% to $21.0 million in 2017, then fell by 9.52% to $19.0 million in 2018, then slipped by 10.53% to $17.0 million in 2019, then changed by 0.0% to $17.0 million in 2020.
- Business Quant data shows PFE's Preferred Shares at $17.0 million in Q1 2020, $17.0 million in Q4 2019, and $18.0 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.18 Bn | 632.42 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.31 Bn | 463.74 Bn | 12.70 Bn | - |
| 3 | Merck | 377.76 Bn | 370.62 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.30 Bn | 295.61 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.84 Bn | 252.94 Bn | 12.86 Bn | - |
| 6 | Amgen | 236.85 Bn | 222.86 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.10 Bn | 178.92 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.40 Bn | 147.70 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.36 Bn | 102.19 Bn | 8.24 Bn | - |
| 10 | Sanofi | 54.99 Bn | 47.61 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2020 | 17.00 Mn |
| Dec 31, 2019 | 17.00 Mn |
| Sep 29, 2019 | 18.00 Mn |
| Jun 30, 2019 | 18.00 Mn |
| Mar 31, 2019 | 19.00 Mn |
| Dec 31, 2018 | 19.00 Mn |
| Sep 30, 2018 | 20.00 Mn |
| Jul 1, 2018 | 20.00 Mn |
| Apr 1, 2018 | 21.00 Mn |
| Dec 31, 2017 | 21.00 Mn |
| Oct 1, 2017 | 22.00 Mn |
| Jul 2, 2017 | 23.00 Mn |
| Apr 2, 2017 | 23.00 Mn |
| Dec 31, 2016 | 24.00 Mn |
| Oct 2, 2016 | 25.00 Mn |
| Jul 3, 2016 | 25.00 Mn |
| Apr 3, 2016 | 26.00 Mn |
| Dec 31, 2015 | 26.00 Mn |
| Jun 28, 2015 | 28.00 Mn |
| Mar 29, 2015 | 28.00 Mn |